Home Cart Sign in  
Chemical Structure| 106516-24-9 Chemical Structure| 106516-24-9

Structure of Sertindole
CAS No.: 106516-24-9

Chemical Structure| 106516-24-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sertindole, a neuroleptic, is one of the antipsychotic medications available, with a high affinity for dopamine D2, serotonin 5-HT2A, 5-HT2C, and α1-adrenergic receptors.

Synonyms: Lu 23-174

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sertindole

CAS No. :106516-24-9
Formula : C24H26ClFN4O
M.W : 440.94
SMILES Code : FC1=CC=C(N2C3=CC=C(Cl)C=C3C(C4CCN(CCN5CCNC5=O)CC4)=C2)C=C1
Synonyms :
Lu 23-174
MDL No. :MFCD00867749
InChI Key :GZKLJWGUPQBVJQ-UHFFFAOYSA-N
Pubchem ID :60149

Safety of Sertindole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335-H413
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Sertindole

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02374567 Dementia Depr... More >>ession Schizophrenia Psychosomatic Disorders Anxiety Disorders Less << Phase 3 Terminated - Germany ... More >> Bezirkskrankenhaus Augsburg Augsburg, Germany Krankenhaus Hedwigshöhe Berlin, Germany Hannover Medical School Hannover, Germany, 30625 Asklepios Fachklinikum Lübben Lübben, Germany Asklepios Fachklinikum Teupitz Teupitz, Germany Less <<
NCT02307396 Schizophrenia ... More >> Schizophrenia and Disorders With Psychotic Features Schizoaffective Disorders Less << Phase 4 Completed - Germany ... More >> Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar Munich, Bavaria, Germany, 81675 Less <<
NCT01765829 Psychosis Nos/Other Phase 3 Unknown November 2015 Spain ... More >> Mental Health Unit Villamartín Recruiting Villamartín, Cádiz, Spain, 11650 Contact: José María Mongil San Juan, MD    0034956040209    cheman45@gmail.com    Principal Investigator: José María Mongil San Juan, MD          Mental Health Unit Baza Recruiting Baza, Granada, Spain, 18800 Contact: Eva Bravo Barba, MD       eva.bravo.barba@gmail.com    Principal Investigator: Eva Bravo Barba, MD          Mental Health Unit Motril Recruiting Motril, Granada, Spain, 18600 Contact: María Luisa Barrigón Estévez, MD    0034958038849    marial.barrigon.sspa@juntadeandalucia.es    Principal Investigator: María Luisa Barrigón Estévez, MD          Mental Health Unit Andújar Recruiting Andújar, Jaén, Spain, 23740 Contact: Fernando Sarramea Crespo, MD, PhD    0034953021717    fernandosarramea@hotmail.com    Principal Investigator: Farnando Sarramea Crespo, MD, PhD          Mental Health Unit Martos Recruiting Martos, Jaén, Spain, 23600 Contact: Miguel Ortigosa Luque, MD       migueortigosa@hotmail.com    Principal Investigator: Miguel Ortigosa Luque, MD          Mental Health Unit Miraflores Not yet recruiting Alcobendas, Madrid, Spain, 28100 Contact: María Luisa Zamarro Arraz, MD, PhD    0034916530108    zamarroluisa@yahoo.es    Principal Investigator: María Luisa Zamarro Arraz, MD, PhD          Hospital Infanta Sofía Not yet recruiting San Sebastian de los Reyes, Madrid, Spain, 28702 Contact: María Rosario Gutiérrez Labrador, MD       rosagutierrez@psiquiatra.e.telefonica.net    Principal Investigator: María Rosario Guitiérrez Labrador, MD          Mental Health Unit Valle del Guadalhorce Not yet recruiting Cártama, Málaga, Spain, 29580 Contact: Daniel Gutiérrez Castillo, MD    0034951033931    dgutierrezcastillo@gmail.com    Principal Investigator: Daniel Gutiérrez Castillo, MD          Mental Health Unit Las Lagunas Not yet recruiting Fuengiróla, Málaga, Spain, 29650 Contact: María Isabel Osuna Carmona, MD       maribelosunac@hotmail.com    Principal Investigator: María Isabel Osuna Carmona, MD          Fundación Argibide Not yet recruiting Pamplona, Navarra, Spain, 31007 Contact: Ignacio Mata Pastor, MD, PhD    0034948266650    nacho.mata70@gmail.com    Principal Investigator: Ignacio Mata Pastor, MD, PhD          Hospital El Tomillar Recruiting Dos Hermanas, Seville, Spain, 41700 Contact: Joaquín Carlos Martín Muñoz, MD, PhD    0034955016083    joaquinmartin@hotmail.com    Principal Investigator: Joaquín Carlos Martín Muñoz, MD, PhD          Hospital Francesc de Borja Recruiting Gandía, Valencia, Spain, 46700 Contact: María Lacruz Silvestre, MD, PhD       maria.lacruz.silvestre@gmail.com    Principal Investigator: María Lacruz Silvestre, MD, PhD          Hospital de Basurto Not yet recruiting Bilbao, Spain, 48013 Contact: Sonia Bustamante Madariaga, MD, Phd    0034944 006137    sonia.bustamantemadariaga@osakidetza.net    Principal Investigator: Sonia Bustamante Madariaga, MD, PhD          Mental Health Unit Tetuán Not yet recruiting Madrid, Spain, 28003 Contact: Mariano Hernández Monsalve, MD, PhD    0034915347363    hergoico@gmail.com    Contact: Ruth Berdún Pe, MD       ruthberdun@yahoo.es    Principal Investigator: Mariano Hernández Monsalve, MD, PhD          Lafora Hospital Not yet recruiting Madrid, Spain, 28049 Contact: Juan Dios Molina Martín, MD, PhD       jmolinamar@hotmail.com    Principal Investigator: Juan Dios Molina Martín, MD, PhD          Hospital Carlos Haya Recruiting Málaga, Spain, 29009 Contact: Fermín Mayoral Cleríes, Md, PhD       fermin.mayoral.sspa@juntadeandalucia.es    Principal Investigator: Fermín Mayoral Cleríes, MD, PhD          Virgen del Rocío Hospital Recruiting Seville, Spain, 41013 Contact: Clara M. Rosso Fernández, MD    0034955013414    claram.rosso.sspa@juntadeandalucia.es    Contact: Miguel Ruiz Veguilla, MD, PhD    0034955013414    mruizveguilla@yahoo.com    Principal Investigator: Miguel Ruiz Veguilla, MD, PhD Less <<
NCT02435095 Schizophrenia Phase 4 Recruiting April 2019 Germany ... More >> RWTH University Hospital Aachen Recruiting Aachen, NRW, Germany, 52074 Contact: Sabrina Schaffrath       saschaffrath@ukaachen.de    Contact: Sarah Lammertz       slammertz@ukaachen.de    Alexianer Aachen GmbH Not yet recruiting Aachen, Germany, 52062 Zentrum für Neurologie und Seelische Gesundheit im Kapuziner Karree Aachen Not yet recruiting Aachen, Germany, 52062 Contact: Frank Bergmann, Dr. med.          LVR Klinik Bonn Recruiting Bonn, Germany, 53111 LVR Klinik Düren Not yet recruiting Düren, Germany, 52353 Klinik und Poliklinik für Psychiatrie und Psychotherapie der Heinrich-Heine-Universität Düsseldorf Recruiting Düsseldorf, Germany, 40629 LVR Klinik Essen Not yet recruiting Essen, Germany, 45147 ViaNobis Gangelt Recruiting Gangelt, Germany, 52538 Klinik Königshof (Abteilung für Allgemeine Psychiatrie) Recruiting Krefeld, Germany, 47807 LVR Klinik Langenfeld Recruiting Langenfeld, Germany, 40764 LVR Klinik Viersen Not yet recruiting Viersen, Germany, 41749 Less <<
NCT00629252 Schizophrenia Not Applicable Terminated(Not enough subjects... More >> have been recruited in the expected period.) Less << - Switzerland ... More >> University Hospital of Psychiatry, Department Neuropsychopharmacology and Brain Imaging Zurich, ZH, Switzerland, CH-8032 Less <<
NCT00612079 Healthy Not Applicable Completed - Switzerland ... More >> University of Psychiatry Hospital Zurich, ZH, Switzerland, CH-8032 Less <<
NCT00759460 Schizophrenia Phase 3 Completed - China ... More >> CN002 Beijing, China, 100083 Less <<
NCT00759421 Schizophrenia Phase 3 Completed - Taiwan ... More >> TWN001 Tapei, Taiwan, 112 Less <<
NCT00654706 Schizophrenia ... More >> Cognition Less << Phase 3 Completed - United States, California ... More >> US017 Garden Grove, California, United States, 92845 US008 National City, California, United States, 91950 US001 Pasadena, California, United States, 91107 US006 Pico Rivera, California, United States, 90660 US011 San Diego, California, United States, 92126 US014 Stanford, California, United States, 94305 US026 Torrance, California, United States, 90502 United States, Colorado US016 Aurora, Colorado, United States, 80045 United States, Florida US015 Orange City, Florida, United States, 32763 US010 Tampa, Florida, United States, 33613 United States, Georgia US007 Atlanta, Georgia, United States, 30308 United States, Illinois US024 Chicago, Illinois, United States, 60640 US002 Joliet, Illinois, United States, 60435 United States, Maryland US012 Baltimore, Maryland, United States, 21204 US027 Glen Burnie, Maryland, United States, 21061 United States, New Hampshire US019 Lebanon, New Hampshire, United States, 03756 United States, New Jersey US021 Clementon, New Jersey, United States, 08021 United States, New York US013 Brooklyn, New York, United States, 11203 US025 Staten Island, New York, United States, 10305 United States, North Carolina US005 Charlotte, North Carolina, United States, 28211 US018 Durham, North Carolina, United States, 27705 United States, Pennsylvania US022 Philadelphia, Pennsylvania, United States, 19139 United States, Texas US023 Austin, Texas, United States, 78754 US020 Dallas, Texas, United States, 75235 US004 Desoto, Texas, United States, 75115 US028 Houston, Texas, United States, 77008 Less <<
NCT00885690 Schizophrenia Not Applicable Terminated(Due to recruitment ... More >>problems) Less << - Denmark ... More >> Aalborg Psychiatric Hospital Aalborg, Denmark, 9000 Sweden Universitets Allmänna Sjukhuset, Malmø UMAS Malmø, Sweden Less <<
NCT00345982 Schizophrenia Not Applicable Completed - Denmark ... More >> Aalborg Psychiatric Hospital Aalborg, Denmark, 9000 Less <<
NCT00763438 Schizophrenia PHASE4 COMPLETED 2025-10-10 FR002, Allonnes, 72703, France
NCT00856583 Schizophrenia Phase 3 Completed - -
NCT02021201 Schizophrenia Phase 4 Terminated(No suitable patient... More >>s could be recruited in the available time period) Less << - Denmark ... More >> Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup Glostrup, Denmark, DK-2600 Less <<
NCT00480844 Schizophrenia Phase 4 Unknown - Israel ... More >> Department of Psychiatry of the Sheba Medical Center Recruiting Ramat Gan, Tel Hashomer, Israel, 52621 Contact: Mark Weiser, Dr    03-5303773    mweiser@netvision.net.il    Principal Investigator: Mark Weiser, Dr          Beer-Yaakov Mental Health Center Not yet recruiting Beer-Yaakov, Israel, 70350 Principal Investigator: Yehuda Abramowitz, Dr          Kfar Shaul Mental Health Center Not yet recruiting Jerusalem, Israel, 91060 Principal Investigator: Alexander Teitelbaum, Dr Less <<
NCT00864045 Schizophrenia Phase 3 Completed - China ... More >> CN001 Beijing, China, 300074 Less <<
NCT01498770 - Completed - -
NCT00856583 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.27mL

0.45mL

0.23mL

11.34mL

2.27mL

1.13mL

22.68mL

4.54mL

2.27mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories